SUPERNUS PHARMACEUTICALS INC. - COMMON STOCK
38,55
24-января-25 15:45:00
15 мин. задержка
Акции
-0,09
-0,23%
Сегодняшний диапазон
38,38 - 39,24
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Supernus Announces Second Quarter 2021 Financial Results
04 авг 2021 15:09:33 Источник Nasdaq GlobeNewswire
-
Supernus to Host Second Quarter 2021 Financial Results Conference Call
22 июл 2021 15:37:21 Источник Nasdaq GlobeNewswire
-
Supernus to Present at Jefferies Virtual Healthcare Conference
25 май 2021 07:30:00 Источник Nasdaq GlobeNewswire
-
24 май 2021 07:30:00 Источник Nasdaq GlobeNewswire
-
Supernus Announces First Quarter 2021 Financial Results
05 май 2021 15:01:00 Источник Nasdaq GlobeNewswire
-
Supernus Announces Paragraph IV ANDA Filing for XADAGO®
04 май 2021 19:49:10 Источник Nasdaq GlobeNewswire
-
Supernus to Host First Quarter 2021 Financial Results Conference Call
27 апр 2021 16:44:01 Источник Nasdaq GlobeNewswire
-
Supernus Announces FDA Approval of Qelbree™ (SPN-812) for the Treatment of ADHD
02 апр 2021 15:58:32 Источник Nasdaq GlobeNewswire
-
Supernus to Present at Cowen Healthcare Conference
26 фев 2021 08:00:00 Источник Nasdaq GlobeNewswire
-
Supernus Announces Fourth Quarter and Full Year 2020 Financial Results
25 фев 2021 15:00:00 Источник Nasdaq GlobeNewswire
-
Supernus to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call
23 фев 2021 08:00:00 Источник Nasdaq GlobeNewswire
-
Supernus Resubmits New Drug Application for SPN-812 for the Treatment of ADHD in Pediatric Patients
08 фев 2021 08:00:00 Источник Nasdaq GlobeNewswire
-
Supernus to Present at J.P. Morgan 39th Annual Healthcare Conference
06 янв 2021 16:29:08 Источник Nasdaq GlobeNewswire